Close

TG Therapeutics (TGTX) Receives IDSMB Recommendation to Continue UNITY-CLL Phase 3

November 22, 2016 7:31 AM EST Send to a Friend
TG Therapeutics, Inc. (Nasdaq: TGTX) announced that the independent Data Safety Monitoring Board (DSMB) providing oversight for the UNITY-CLL Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login